Viatronix Incorporated Announces the Latest Release of Its V3D-ColonŽ Software Now Offering the First 510(k) Approved Colon CAD for the U.S. Market

Thursday, August 12, 2010 Drug News J E 4

STONY BROOK, N.Y., Aug. 11 /PRNewswire/ -- Viatronix Incorporated, a Stony Brook, New York, based company announced the release of the latest version of its leading edge V3D-Colon software with the option to have the industry's first FDA 510(k) approved colon CAD, VeraLook™ by iCAD.

"We believe colon CAD when integrated with our latest V3D-Colon module provides the reading physician a distinct advantage along with an additional level of confidence," said Zaffar Hayat, President and CEO of Viatronix Incorporated.  "The seamless integration of third party CAD products into our user friendly interface results in an uninterrupted workflow for the user".  

The optional VeraLook Colon CAD module provides a list of CAD marks which are displayed in a numbered list along with bold colored markers on both 2D and 3D images while navigating through the Viatronix V3D-Colon interface. V3D-Colon with the CAD option has been available outside the U.S. since early 2009 and now with FDA approval colon CAD is available for sale in the United States.  

About Viatronix

Viatronix is a leading innovator and developer of 2D/3D medical imaging and diagnostic software. The software enables physicians to interactively view vital organs and anatomical structures within the human body from data acquired by standard medical imaging equipment in minimally or non-invasive methods. Viatronix's user interface is well known for ease of use, efficient workflow and intuitive diagnostic tools.

Viatronix, through application of its V3DŽ technology, is developing additional innovative products that will be useful in early detection of other diseases, treatment planning, intervention, and follow-up evaluation. Viatronix, Inc. is located in Stony Brook, NY. To learn more, call us toll free at 1-866-887-4636 or log on to

SOURCE Viatronix Incorporated



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
MedQuist Reports Second Quarter 2010 Results with ...
International Hydroponics Expert Uses Pioneering N...